Global Infertility Market Insights on Symptoms, Treatment, Challenges and Opportunities 2018

Global Infertility Market Information; By Sex (Males, Females And Unexplained), By Diagnosis (Men Diagnostic Tests (Semen Analysis, Genetic Testing, Testicular Biopsy, And Other) And Women Diagnostic Tests (Hysteroscopy, Laparoscopy, Ovulation Testing, Hysterosalpingography And Others)) And General Diagnostic Tests (Genetic Testing, Hormone Testing, Microscopic Analysis, Imaging, And Others), By Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment And Others), By Techniques (Assisted Reproductive Technology (Art), Intrauterine Insemination, And Surgery (Laparoscopic Or Hysteroscopic Surgery, Tubal Surgeries And Others) And Others) - Forecast To 2023

Market Research Future (MRFR)’s analysis, the market for infertility stood at 11.2 billion in 2016 and is projected to expand at a CAGR of 4.6 % during the forecast period ending 2023.

Some of the key vendors operating and profiled in the report are Halotech DNA, SCSA Diagnostics, Inc., Andrology Solutions, Zydus Cadila Healthcare Ltd, Androvia LifeSciences, Aetna Inc., Bayer Healthcare, and EMD Serono, Inc.,

Get Sample Copy of Research Report: https://www.marketresearchfuture.com/sample_request/6145

Rise In Risk Factors Is The Prime Reason For Market Growth

The increase in risk factors for the global infertility market is sedentary lifestyles, increasing age at marriage, substance abuse, environmental factors, genetic abnormalities, stress, obesity, prostate cancer, varicocele, and others. Smoking, alcohol, anabolic steroid use, and illicit drug use is positively correlated to the growth of infertility. Cancer treatment such as chemotherapy, radiation, also affects fertility. Late marriage and hormonal disorders are other causes associated with infertility. Women infertility is caused by Polycystic ovary syndrome (PCOS), Functional hypothalamic amenorrhea, pelvic infection, ruptured appendicitis, gonorrhea or chlamydia, endometriosis, or abdominal surgery.

To gauge an accurate understanding of the market potentiality, the report is segmented by sex, diagnosis, drugs, techniques, and regions.

Based on the sex, the market is bifurcated as males, females and unexplained.

Based on the diagnosis, the market is bifurcated as men diagnostic tests (semen analysis, genetic testing, testicular biopsy, and other), women diagnostic tests (hysteroscopy, laparoscopy, ovulation testing, hysterosalpingography and others), and general diagnostic tests (genetic testing, hormone testing, microscopic analysis, imaging, and others)

Based on drugs, the market is segmented into clomiphene citrate, letrozole, serophene, hormone treatment and others.

Based on techniques, the market is segmented by assisted reproductive technology (ART), intrauterine insemination, and surgery. The surgery segment is further sub-segmented by laparoscopic or hysteroscopic surgery, tubal surgeries and others.

Based on geography, the market is charted according to North America, Europe, Asia Pacific, Middle East, and Africa.

Growth In Awareness and Growing Number of fertility Clinics Is Driving A Large Demand

There has been a keen awareness regarding infertility with concurrent development of fertility clinics. The advent of assisted reproductive techniques has resulted in a significant adoption of these services by the market.

Poor Efficacy of Treatment and High Cost Sssociated May Hamper Market’s Growth

The prime market constraints include the high cost of the procedure, side effects of the drug therapy and social taboos for Infertility treatment and others.

Browse Complete 108 Pages Premium Research Report Enabled with 121 Respective Tables and Figures at: https://www.marketresearchfuture.com/reports/infertility-market-6145

Regional Analysis

The US accounts for the maximum market share of the global infertility market attributed to increasing pool of awareness, high income, and good reimbursement scenario. Europe led by Germany, France, and the U.K. is expected to be the second largest market.

Infertility Market to Cruise on High Trajectory on Account of the Rising Awareness and the Advent of Assisted Reproductive Technology

Advancing technologies within the Infertility treatment is driving the market and will see strategic growth over the next five years. The Asia Pacific, dominated by China, and India is projected to be the fastest growing market owing to a large population with unmet needs and also because the rate of male infertility is highest in South Asia.

Inquire for Discount at: https://www.marketresearchfuture.com/check-discount/6145

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.